Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alba Moratiel Pellitero"'
Autor:
Maria Marti Pi, Marta Gascon Ruiz, Diego Casas-Deza, Irene Torres Ramon, Maria Zapata-Garcia, Andrea Sesma, Julio Jose Lambea- Sorrosal, Maria Alvarez, Elisa Quilez, Maria Zurera Berjaga, Alba Moratiel Pellitero, Ines Ruiz Moreno, Ana Goas Gomez, Dolores Isla, José Miguel Arbonés-Mainar
Publikováno v:
Journal of Clinical Oncology. 40:e24093-e24093
e24093 Background: Malnutrition is a condition with great impact in oncology patients. Poor nutritional status is often associated with increased morbidity and mortality, increased toxicity and reduced tolerance to chemotherapy, among other complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9506b86465b2f362f14a9debbb44c3d
https://doi.org/10.1200/jco.2022.40.16_suppl.e24093
https://doi.org/10.1200/jco.2022.40.16_suppl.e24093
Autor:
Jose Ramón Paño Pardo, Maria Zurera Berjaga, Natalia Alonso Marin, Alba Moratiel Pellitero, Maitane Ocariz Diez, Rodrigo Lastra del Prado, Marta Gascón Ruiz, Ines Ruiz Moreno, Mara Cruellas, María Álvarez Alejandro, María Zapata García
Publikováno v:
Medicina Paliativa.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6b7f8604a7839aded99f37325e94195
https://doi.org/10.20986/medpal.2021.1265/2021
https://doi.org/10.20986/medpal.2021.1265/2021
Autor:
Natalia Alonso Marin, Jose Manuel Vinuesa Hernando, Maria Zapata-Garcia, Ines Ruiz Moreno, Irene Torres, Maria Zurera Berjaga, Carlos Camacho Fuentes, Elisa Quilez, Maria Marti Pi, Mara Cruellas, Ana Goas Gomez, Alba Moratiel Pellitero, R. Lastra, Marta Gascon Ruiz, J. Lambea, Maitane Ocáriz, Maria Alvarez, Andrea Sesma Goñi
Publikováno v:
Journal of Clinical Oncology. 39:e16537-e16537
e16537 Background: Renal cell carcinoma (RCC) have low prevalence but it incidence is increasing. For a correct therapeutic approach, it is important to carry out a correct prognostic stratification. Several prognostication systems have been proposed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1e1688a3a72beba668ac15733b51736
https://doi.org/10.1200/jco.2021.39.15_suppl.e16537
https://doi.org/10.1200/jco.2021.39.15_suppl.e16537
Autor:
Dolores Isla, Ana Goas Gomez, Maria Marti Pi, Ines Ruiz Moreno, Maitane Ocáriz, Natalia Alonso Marin, Maria Zurera Berjaga, Diego Casas-Deza, Marta Gascón Ruiz, Andrea Sesma Goñi, Maria Zapata-Garcia, Elisa Quilez, Julio Jose Lambea Sorrosal, Maria Alvarez, Jose M. Arbones-Mainar, Alba Moratiel Pellitero, Irene Torres
Publikováno v:
Journal of Clinical Oncology. 39:e24065-e24065
e24065 Background: Malnutrition is one of the most prevalent problems among oncological patients. It reduces the response to treatments and negatively impacts survival. In 2019, a consensus criteria for diagnosing malnutrition (GLIM criteria) were pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa43b434f87eaa11f0d6f14aa2469bc
https://doi.org/10.1200/jco.2021.39.15_suppl.e24065
https://doi.org/10.1200/jco.2021.39.15_suppl.e24065
Autor:
Maria Alvarez, Ines Ruiz Moreno, Marta Gascon Ruiz, Alba Moratiel Pellitero, Maitane Ocáriz, Dolores Isla, Ana Goas Gomez, Andrea Sesma Goñi, Maria Zurera Berjaga, Maria Zapata-Garcia, Raquel Andrés, Natalia Alonso Marin, Maria Marti Pi, R. Lastra, Mara Cruellas
Publikováno v:
Journal of Clinical Oncology. 39:e22502-e22502
e22502 Background: Inherited mutations in the CHEK2 gene have been associated with an increased lifetimerisk of develop breast cancer (BC). The main objective of the study is to identify in our population the prevalence of mutations in the CHEK2 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::744d5611b50970ea498661146eb8a8c1
https://doi.org/10.1200/jco.2021.39.15_suppl.e22502
https://doi.org/10.1200/jco.2021.39.15_suppl.e22502
Autor:
Carlos Camacho Fuentes, Elisa Quilez, Andrea Sesma Goñi, Natalia Alonso Marin, Alba Moratiel Pellitero, Maitane Ocáriz, Julio Jose Lambea Sorrosal, Irene Torres, Marta Gascón Ruiz, Maria Alvarez, R. Lastra, Carla Sanchez Cortes, Dolores Isla, Maria Zapata-Garcia, Ana Goas Gomez, Maria Zurera Berjaga, Ines Ruiz Moreno, Mara Cruellas, Maria Marti Pi
Publikováno v:
Journal of Clinical Oncology. 39:e21052-e21052
e21052 Background: Immunotherapy is proposed as a therapeutic novelty in metastatic non-small cell lung cancer (NSCLC), in many cases already in front line. It presents different adverse effects than traditional schemes, due to the stimulation of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17bdef2d19d6b8a0d411e6b563e42d3
https://doi.org/10.1200/jco.2021.39.15_suppl.e21052
https://doi.org/10.1200/jco.2021.39.15_suppl.e21052